188 related articles for article (PubMed ID: 36413344)
1.
Suman SK; Mukherjee A; Pandey U; Chakraborty A; Rakshit S; Tawate M; Sarma HD
Cancer Biother Radiopharm; 2023 Feb; 38(1):38-50. PubMed ID: 36413344
[No Abstract] [Full Text] [Related]
2. Preparation and preliminary bioevaluation studies of
Suman SK; Kameswaran M; Pandey U; Sarma HD; Dash A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):850-859. PubMed ID: 31461549
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of
Sharma R; Mukherjee A; Kumar A; Sarma HD
Cancer Biother Radiopharm; 2024 Feb; 39(1):64-74. PubMed ID: 38363819
[No Abstract] [Full Text] [Related]
4. Development and preclinical studies of
Lam K; Chan C; Reilly RM
MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
[TBL] [Abstract][Full Text] [Related]
5. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.
Ma T; Sun X; Cui L; Gao L; Wu Y; Liu H; Zhu Z; Wang F; Liu Z
J Nucl Med; 2014 Jun; 55(6):1002-7. PubMed ID: 24732154
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Evaluation of CD20 Expression Using
Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
[TBL] [Abstract][Full Text] [Related]
8. Toward Understanding the Binding Synergy of Trastuzumab and Pertuzumab to Human Epidermal Growth Factor Receptor 2.
Sharma R; Kumbhakar M; Mukherjee A
Mol Pharm; 2021 Dec; 18(12):4553-4563. PubMed ID: 34757737
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of a
Xu Y; Wang L; Pan D; Yu C; Mi B; Huang Q; Sheng J; Yan J; Wang X; Yang R; Yang M
Br J Radiol; 2019 Dec; 92(1104):20190425. PubMed ID: 31593482
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.
Beylergil V; Morris PG; Smith-Jones PM; Modi S; Solit D; Hudis CA; Lu Y; O'Donoghue J; Lyashchenko SK; Carrasquillo JA; Larson SM; Akhurst TJ
Nucl Med Commun; 2013 Dec; 34(12):1157-65. PubMed ID: 24100444
[TBL] [Abstract][Full Text] [Related]
12.
Kang L; Li C; Yang Q; Sutherlin L; Wang L; Chen Z; Becker KV; Huo N; Qiu Y; Engle JW; Wang R; He C; Jiang D; Xu X; Cai W
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1470-1481. PubMed ID: 34677626
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of
Shi D; Fu W; Tan H; Lin Q; Shi H; Cheng D
Mol Pharm; 2024 Jan; 21(1):303-312. PubMed ID: 38109713
[TBL] [Abstract][Full Text] [Related]
14.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
15. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts.
Oude Munnink TH; de Vries EG; Vedelaar SR; Timmer-Bosscha H; Schröder CP; Brouwers AH; Lub-de Hooge MN
Mol Pharm; 2012 Nov; 9(11):2995-3002. PubMed ID: 23003202
[TBL] [Abstract][Full Text] [Related]
17. Comparative
Sharma R; Kameswaran M; Dash A
Cancer Biother Radiopharm; 2020 Apr; 35(3):177-189. PubMed ID: 32196365
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
